PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAlpha-tocopherol
Alpha-tocopherol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
276 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.81—836319
Fatty liverD005234EFO_0003934—1826319
Liver diseasesD008107EFO_0001421K70-K771514111
Diabetes mellitusD003920EFO_0000400E08-E131212611
ObesityD009765EFO_0001073E66.9111238
Oxidative stressD018384EFO_1001905——2—158
InflammationD007249MP_0001845——21147
Wounds and injuriesD014947—T14.8—2—114
OsteoradionecrosisD010025EFO_1001821———1124
InfectionsD007239EFO_0000544———2114
Show 37 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SyndromeD013577———64—615
FibrosisD005355——263——9
Chronic kidney failureD007676EFO_0003884N18.6—43—17
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9111—36
Obstructive lung diseasesD008173——111—36
Alzheimer diseaseD000544EFO_0000249F03113—16
OverweightD050177—E66.3—11—46
Breast neoplasmsD001943EFO_0003869C50122—16
OsteonecrosisD010020EFO_0004259M87—11—35
Prostatic neoplasmsD011471—C61112—15
Show 64 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnemiaD000740EFO_0004272D64.922——36
AsthmaD001249EFO_0000270J4532——16
Covid-19D000086382—U07.1—2——35
Cognitive dysfunctionD060825—G31.84—2——24
PneumoniaD011014EFO_0003106J18—2——13
Cystic fibrosisD003550EFO_0000390E84—2——13
MucositisD052016EFO_1001898——1——23
DepressionD003863—F33.9—1——23
Depressive disorderD003866EFO_1002014F32.A—1——23
Acne vulgarisD000152EFO_0003894L70—1——23
Show 64 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———3———58
Iron deficienciesD000090463—E61.11———45
Heart failureD006333EFO_0003144I503———14
Iron-deficiency anemiaD018798—D501———34
Allergic rhinitisD065631—J30.92———13
RhinitisD012220EFO_0008521J311———23
HypertensionD006973EFO_0000537I101———12
FatigueD005221—R53.831———12
HypersensitivityD006967EFO_0003785T78.401———12
Pulmonary arterial hypertensionD000081029——1————1
Show 9 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Alopecia areataD000506EFO_0004192L63————44
AlopeciaD000505—L64————44
HypotrichosisD007039——————44
AnxietyD001007EFO_0005230F41.1————33
Cardiovascular diseasesD002318EFO_0000319I98————33
Skin agingD015595EFO_0005422—————33
MyalgiaD063806—M79.1————22
Beta-thalassemiaD017086Orphanet_848D56.1————22
ThalassemiaD013789EFO_1001996D56————22
Metabolic syndromeD024821EFO_0000195E88.810————22
Show 87 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
37 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use